WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 30, 2024-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of November:

• Guggenheim’s Inaugural Healthcare Innovation Conference on Monday, November 11, 2024 at 2:00 pm (EST)
• Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 9:30 am (GMT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241030557532/en/

Media
media@incyte.com

Investors
ir@incyte.com

Source: Incyte